ATE202139T1 - Von parasit gewonnener widerstand - Google Patents

Von parasit gewonnener widerstand

Info

Publication number
ATE202139T1
ATE202139T1 AT91117193T AT91117193T ATE202139T1 AT E202139 T1 ATE202139 T1 AT E202139T1 AT 91117193 T AT91117193 T AT 91117193T AT 91117193 T AT91117193 T AT 91117193T AT E202139 T1 ATE202139 T1 AT E202139T1
Authority
AT
Austria
Prior art keywords
parasite
gene fragment
dna
host
binding site
Prior art date
Application number
AT91117193T
Other languages
English (en)
Inventor
Stephen A Johnston
John C Sanford
Original Assignee
Johnston Stephen Ph D
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnston Stephen Ph D, Cornell Res Foundation Inc filed Critical Johnston Stephen Ph D
Application granted granted Critical
Publication of ATE202139T1 publication Critical patent/ATE202139T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/18011—Details ssRNA Bacteriophages positive-sense
    • C12N2795/18111—Leviviridae
    • C12N2795/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/18011—Details ssRNA Bacteriophages positive-sense
    • C12N2795/18111—Leviviridae
    • C12N2795/18141—Use of virus, viral particle or viral elements as a vector
    • C12N2795/18143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
AT91117193T 1985-03-21 1986-03-17 Von parasit gewonnener widerstand ATE202139T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71426385A 1985-03-21 1985-03-21

Publications (1)

Publication Number Publication Date
ATE202139T1 true ATE202139T1 (de) 2001-06-15

Family

ID=24869345

Family Applications (2)

Application Number Title Priority Date Filing Date
AT91117193T ATE202139T1 (de) 1985-03-21 1986-03-17 Von parasit gewonnener widerstand
AT86902165T ATE201444T1 (de) 1985-03-21 1986-03-17 Vom parasit abgeleiteter widerstand

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT86902165T ATE201444T1 (de) 1985-03-21 1986-03-17 Vom parasit abgeleiteter widerstand

Country Status (5)

Country Link
EP (3) EP0215907B1 (de)
JP (2) JPS62502863A (de)
AT (2) ATE202139T1 (de)
DE (2) DE3650756T2 (de)
WO (1) WO1986005516A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608241B1 (en) * 1985-10-29 2003-08-19 Monsanto Technology Llc Protection of plants against viral infection
JPS63501923A (ja) * 1985-12-05 1988-08-04 フレツド　ハツチンソン　キヤンサ−　リサ−チ　センタ− レトロウイルス疾病状態の治療のためのアンチセンスｒｎａ
NZ219472A (en) * 1986-03-28 1990-08-28 Calgene Inc Regulation of phenotype in plant cells using dsdna constructs
US5107065A (en) * 1986-03-28 1992-04-21 Calgene, Inc. Anti-sense regulation of gene expression in plant cells
US5453566A (en) * 1986-03-28 1995-09-26 Calgene, Inc. Antisense regulation of gene expression in plant/cells
EP0240332B1 (de) * 1986-04-02 1995-07-12 Pioneer Hi-Bred International, Inc. Pflanzen, resistent gegen den Anti-sens RNS aufweisenden Virus
US5194428A (en) * 1986-05-23 1993-03-16 Worcester Foundation For Experimental Biology Inhibition of influenza virus replication by oligonucleotide phosphorothioates
US5637573A (en) * 1986-05-23 1997-06-10 Agrawal; Sudhir Influenza virus replication inhibiting oligonucleotide analogues and their pharmaceutical compositions
US5120657A (en) * 1986-12-05 1992-06-09 Agracetus, Inc. Apparatus for genetic transformation
IL84459A (en) * 1986-12-05 1993-07-08 Agracetus Apparatus and method for the injection of carrier particles carrying genetic material into living cells
ES2026581T3 (es) * 1987-02-20 1992-05-01 Takeda Chemical Industries, Ltd. Plantas resistentes a infeccion por virus de mosaico de pepino.
AU616211B2 (en) * 1987-03-09 1991-10-24 Upjohn Company, The Transgenic animal cells resistant to viral infection
EP0331939B1 (de) * 1988-02-16 2001-11-14 Greatbatch Gen-Aid, Ltd Modifizierte Zellen mit Resistenz gegen Retroviralinfektionen
JPH04501052A (ja) * 1988-02-26 1992-02-27 ザ・ウスター・フアウンデーシヨン・フオー・バイオメデイカル・リサーチ 外来性オリゴヌクレオチドによるｈｔｌｖ―３の抑制
NL9000773A (nl) * 1990-04-02 1991-11-01 Rijkslandbouwhogeschool Werkwijze voor het beschermen van planten tegen pathogenen.
AU656136B2 (en) * 1990-04-20 1995-01-27 General Hospital Corporation, The Methods of preventing viral replication
US5610050A (en) * 1990-04-20 1997-03-11 The General Hospital Corporation Methods of preventing viral replication
NZ239638A (en) * 1990-09-05 1993-12-23 Univ North Carolina State Bacteriophage resistant recombinant bacteria and their use in
US5514570A (en) * 1991-08-27 1996-05-07 Cornell Research Foundation Squash mosaic virus genes and plants transformed therewith
WO1993010227A1 (en) * 1991-11-14 1993-05-27 Charles Weissmann Transgenic animals lacking prion proteins
US6228579B1 (en) 1997-11-14 2001-05-08 San Diego State University Foundation Method for identifying microbial proliferation genes
GB9827152D0 (en) 1998-07-03 1999-02-03 Devgen Nv Characterisation of gene function using double stranded rna inhibition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983001451A1 (en) * 1981-10-23 1983-04-28 Molecular Biosystems Inc Oligonucleotide therapeutic agent and methods of making same
NZ209840A (en) * 1983-10-17 1988-11-29 Kaji Akira A method of inhibiting viral propagation by hybridising dna with the viral rna thus blocking its action
DE3486479T2 (de) * 1983-10-20 2001-09-20 The Research Foundation Of State University Of New York, Albany Regulierung der Genexpression durch Translationshemmung unter Verwendung von mRNA hindernder Komplementär-RNA
EP0178314A1 (de) * 1984-04-26 1986-04-23 The Australian National University Klonierungsverfahren für doppelstrang-dns und dessen verwendung bei der herstellung viraler genklone
CA1288073C (en) * 1985-03-07 1991-08-27 Paul G. Ahlquist Rna transformation vector
US6617496B1 (en) * 1985-10-16 2003-09-09 Monsanto Company Effecting virus resistance in plants through the use of negative strand RNAs
US6608241B1 (en) * 1985-10-29 2003-08-19 Monsanto Technology Llc Protection of plants against viral infection
JPS63501923A (ja) * 1985-12-05 1988-08-04 フレツド　ハツチンソン　キヤンサ−　リサ−チ　センタ− レトロウイルス疾病状態の治療のためのアンチセンスｒｎａ
GB8601680D0 (en) * 1986-01-23 1986-02-26 Agricultural Genetics Co Modification of plant viruses

Also Published As

Publication number Publication date
EP0215907B1 (de) 2001-05-23
DE3650756T2 (de) 2001-10-04
JP2000300254A (ja) 2000-10-31
ATE201444T1 (de) 2001-06-15
DE3650759D1 (de) 2001-07-19
WO1986005516A1 (en) 1986-09-25
DE3650756D1 (de) 2001-06-28
EP0215907A1 (de) 1987-04-01
JPS62502863A (ja) 1987-11-19
DE3650759T2 (de) 2002-05-08
EP0477994B1 (de) 2001-06-13
EP0477994A1 (de) 1992-04-01
EP1213348A2 (de) 2002-06-12
EP0215907A4 (de) 1989-06-26

Similar Documents

Publication Publication Date Title
ATE202139T1 (de) Von parasit gewonnener widerstand
Beier et al. UAG readthrough during TMV RNA translation: isolation and sequence of two tRNAsTyr with suppressor activity from tobacco plants
Tabak et al. A method for the recovery of DNA from agarose gels
Wu Adenovirus DNA-directed transcription of 5.5 S RNA in vitro.
FI102387B1 (fi) Menetelmä ribonukleiinihapon (RNA) valmistamiseksi
YU180386A (sh) Genomna modifikacija kvasca roda pichia koja je selektivna po lokaciji
ATE236269T1 (de) Ein elektrochemiluminescenter nachweis von nukleinsäuren auf basis der selbsttragenden sequenzreplikation
US4416988A (en) Detection and isolation of enkephalin mRNA using a synthetic oligodeoxynucleotide
Dame et al. Cloning and characterization of a ribosomal RNA gene from Plasmodium berghei
EP0331939A3 (de) Verfahren und Zusammensetzungen zum Widerstand gegen Retroviralinfektionen
Musso et al. The 5′-terminal nucleotide sequence of galactose messenger ribonucleic acid of Escherichia coli
Pace et al. Long insertions within telomeres contribute to chromosome size polymorphism in Plasmodium berghei
Ehresmann et al. The 3′‐terminal nucleotide sequence of the 16 S ribosomal RNA from Escherichia coli
IKEDA In vitro Synthesis of tRNATyr Precursors and their Conversion to 4S RNA
Richard et al. A high molecular weight topoisomerase I from Xenopus laevis ovaries
Silverman et al. The nucleotide sequence of lysine tRNA 2 from Drosophila
ATE256200T1 (de) Methode zur selektion von nukleinsäuren auf der basis ihrer struktur
Dame et al. Identification of 5 S and 5.8 S ribosomal RNA molecules and their genes in Plasmodium berghei
Gordon et al. Restriction enzyme cleavage mapping of T7 virus early region
JPS57130998A (en) Human interferon-beta-gene
Sedat et al. Direct determination of DNA nucleotide sequences. Structure of large specific fragments of bacteriophage φX174 DNA
Rauè et al. Occurrence in Bacillus licheniformis of Two Species of 5‐S RNA with Multiple Differences in Primary Structure
Kapitza et al. Effect of Escherichia coli p factor and RNase III on the formation of~ bX174 RNA in vitro
Krol et al. Recognition of RNA by ribosomal protein S1: Interaction of S1 with 23 S rRNA of Escherichia coli
KR102035654B1 (ko) 항균 펩타이드를 생산하는 돌연변이 곤충 세포주 또는 이의 제조방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties